YDESW — YD Bio Ltd
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 2011674 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 13,779,397 | 6,007,615 | 16,635,060 |
| Jun 2025 | — | — | — | — | 5,841,086 | 469,520 | 752,935 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,238,359
Inventory
$1,879,542
Receivables
$712,263
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$510,360
EBITDA
$-1,357,195
Free Cash Flow
$-3,875,569
Enterprise Value
—
Total Cash
$3,132,298
Total Debt
$22,265
Shares Out
—
Trailing EPS
—
Book Value
$4.57
ROE
-42.7%
ROA
-25.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 596,817 | -5,268,318 | -8,311,316 | 13,779,397 | 16,635,060 | — | -6,596,706 |
| Dec 2024 | 510,360 | -1,462,423 | -1,411,559 | 6,864,226 | 273,980 | — | -1,222,681 |
| Dec 2023 | 350,131 | -7,116 | 13,560 | 321,212 | 298,218 | — | -55,657 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | $95.22B | $429.24 | — |
| NTRA | Natera, Inc. | $47.24B | $327.72 | — |
| LH | LABCORP HOLDINGS INC. | $27.52B | $339.34 | — |
| DGX | QUEST DIAGNOSTICS INC | $26.92B | $243.87 | — |
| THC | TENET HEALTHCARE CORP | $22.43B | $278.59 | — |
News headlines (Yahoo Finance, 1h cache)
YD Bio Launches a Physician-Partnership Initiative in Taiwan with the Announcement of Two Nutraceutical Products in Collaboration with the Taiwan Chronic Disease Healthcare Association and the Future
2026-08-11 12:00 · Yahoo
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research
2026-08-04 12:00 · Yahoo
YD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada
2026-07-28 12:00 · Yahoo
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services
2026-07-23 12:00 · Yahoo
YD Bio Expands U.S. Laboratory Footprint to 46 States, Strengthening DNA-Methylation Early Cancer Detection Operations
2026-07-02 12:00 · Yahoo
YD Bio Limited Reports Full Year 2025 Financial Results
2026-04-30 22:00 · Yahoo
YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States
2026-03-31 12:00 · Yahoo
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
2026-03-17 12:00 · Yahoo
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations.
2026-01-13 15:00 · Yahoo
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
2026-01-06 14:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.